Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Clinical Nuclear Medicine
ISSN 0363-9762 · eISSN 1536-0229 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1976
Clinical Nuclear Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 9.44; JCR Q1 (journal website); hybrid open access; median 68 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 75%; 630 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Nuclear Medicine is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging and Pathology Studies, Radiopharmaceutical Chemistry and Applications and Medical Imaging Techniques and Applications, together about 40.9% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
CLINICAL NUCLEAR MEDICINE welcomes the submission of material related to the clinical aspects of nuclear medicine. Emphasis is on scanning, imaging and related subjects. Electronic submissions are acceptable provided the illustrations are prepared in the designated manner as stated below.
Source: LetPub
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief Patrick M. CollettiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging and Pathology StudiesMedicine19.7%
- Radiopharmaceutical Chemistry and ApplicationsMedicine10.7%
- Medical Imaging Techniques and ApplicationsMedicine10.4%
- Neuroendocrine Tumor Research AdvancesMedicine4.3%
- Sarcoma Diagnosis and TreatmentMedicine3.8%
- Thyroid Cancer Diagnosis and TreatmentMedicine3.6%
- Peptidase Inhibition and AnalysisMedicine3.5%
- Prostate Cancer Treatment and ResearchMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING · rank 8/217
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.44LetPub ·
- Impact factor (publisher)
- 9.6Publisher website ·
- CiteScore 2026-06
- 2.8LetPub ·
- SJR 2026-06
- 0.58LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 53LetPub ·
- h-index
- 91OpenAlex ·
- i10-index
- 4,607OpenAlex ·
- 2-year mean citedness
- 1.89OpenAlex ·
- Self-citation rate
- 33.3%LetPub ·
- Share of gold OA articles
- 14.1%LetPub ·
Volume
- Articles per year
- 283LetPub ·
Articles by year OpenAlex count · 20,391 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 417 | 61 | 78 |
| 2025 | 630 | 67 | 947 |
| 2024 | 625 | 56 | 2,132 |
| 2023 | 521 | 63 | 2,563 |
| 2022 | 534 | 67 | 3,214 |
| 2021 | 483 | 35 | 4,334 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
68 daysMedian, submission to acceptance · P25–P75 46 days – 86 days
- Acceptance to online
- median 38 days (97 articles)
- Submission to online
- median 113 days
- Sample
- 97 articles with submission and acceptance dates (1,258 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1976
- ISSN
- 0363-9762
- Electronic ISSN
- 1536-0229
- Latest issue on the website
- Volume 51, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Clinical Nuclear Medicine
What CAS zone is Clinical Nuclear Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Nuclear Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Nuclear Medicine?
The latest impact factor listed by LetPub is 9.44; CiteScore 2.8, h-index 91.
How long does peer review take at Clinical Nuclear Medicine?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 46–86 days); authors report an average review time of about 2 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Clinical Nuclear Medicine in?
The journal's website gives JCR Q1; by category, RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q1 (8/217). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Clinical Nuclear Medicine?
According to LetPub and DOAJ records, Clinical Nuclear Medicine is indexed in SCIE and Scopus.
Is Clinical Nuclear Medicine open access, and what is the APC?
Clinical Nuclear Medicine is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .